Clinical Trial Update: An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY) [Phase 4]

View source ↗

Summary

Phase 4 interventional study GLORY assessed the efficacy and tolerability of Targin (oxycodone/naloxone) in adults with non-malignant chronic pain; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• TARGIN (oxycodone/naloxone)

Snippet

Sponsor: Mundipharma Korea Ltd | Conditions: Chronic Pain | Phase 4 | Status: COMPLETED | Results posted: 2017-03-10